2022 SITC 1250 A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy d Published Date November 10, 2022 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen